• 1
    Reddy SV, Roodman GD 1998 Control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 8: 117.
  • 2
    Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345357.
  • 3
    Theill LE, Boyle WJ, Penninger JM 2002 RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 20: 795823.
  • 4
    Katagiri T, Takahashi N 2002 Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8: 147159.
  • 5
    Gerke V, Moss SE 1997 Annexins and membrane dynamics. Biochim Biophys Acta 1357: 129154.
  • 6
    Gerke V, Moss SE 2002 Annexins: From structure to function. Physiol Rev 82: 331371.
  • 7
    Siever DA, Erickson HP 1997 Extracellular annexin II. Int J Biochem Cell Biol 29: 12191223.
  • 8
    Mizwicki MT, Norman AW 2003 Two key proteins of the vitamin D endocrine system come into crystal clear focus: Comparison of the X-ray structures of the nuclear receptor for 1alpha,25(OH)2 vitamin D3, the plasma vitamin D binding protein, and their ligands. J Bone Miner Res 18: 795806.
  • 9
    Takahashi S, Reddy SV, Chirgwin JM, Devlin R, Haipek C, Anderson J, Roodman GD 1994 Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J Biol Chem 269: 2869628701.
  • 10
    Menaa C, Devlin RD, Reddy SV, Gazitt Y, Choi SJ, Roodman GD 1999 Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J Clin Invest 103: 16051613.
  • 11
    MacDonald BR, Takahashi N, McManus LM, Holahan J, Mundy GR, Roodman GD 1987 Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures. Endocrinology 120: 23262333.
  • 12
    Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HF, Evans BA, Thompson RP, Powell JJ, Hampson GN 2003 Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 32: 127135.
  • 13
    Kurihara N, Chenu C, Miller M, Civin C, Roodman GD 1990 Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology 126: 27332741.
  • 14
    Huan JN, Li J, Han Y, Chen K, Wu N, Zhao AZ 2003 Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance. J Biol Chem 278: 4563845650.
  • 15
    Khosla S 2001 Minireview: The OPG/RANKL/RANK system. Endocrinology 142: 50505055.
  • 16
    Schaeffer HJ, Weber MJ 1999 Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol 19: 24352444.
  • 17
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309319.
  • 18
    Uy HL, Dallas M, Calland JW, Boyce BF, Mundy GR, Roodman GD 1995 Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. J Bone Miner Res 10: 295301.
  • 19
    Atkins GJ, Haynes DR, Geary SM, Loric M, Crotti TN, Findlay DM 2000 Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone 26: 653661.
  • 20
    Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N 1995 Modulation of osteoclast differentiation by local factors. Bone 17: 87S91S.
  • 21
    O'Brien CA, Gubrij I, Lin SC, Saylors RL, Manolagas SC 1999 STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone. J Biol Chem 274: 1930119308.
  • 22
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 35973602.
  • 23
    Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K, Suda T 2000 Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. Endocrinology 141: 47114719.